Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CARRECA, Ignazio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.851
EU - Europa 1.895
AS - Asia 1.501
SA - Sud America 183
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.809
SG - Singapore 523
CN - Cina 427
RU - Federazione Russa 399
IT - Italia 323
DE - Germania 290
UA - Ucraina 229
HK - Hong Kong 147
BR - Brasile 146
FI - Finlandia 134
PL - Polonia 124
VN - Vietnam 117
FR - Francia 88
GB - Regno Unito 85
IE - Irlanda 74
JP - Giappone 69
KR - Corea 53
SE - Svezia 50
IN - India 38
RO - Romania 23
NL - Olanda 19
BD - Bangladesh 17
MX - Messico 17
TR - Turchia 17
CA - Canada 15
IQ - Iraq 15
BE - Belgio 14
TH - Thailandia 10
AT - Austria 9
ES - Italia 9
VE - Venezuela 9
AR - Argentina 8
SA - Arabia Saudita 7
ZA - Sudafrica 7
CH - Svizzera 6
PH - Filippine 6
UZ - Uzbekistan 6
AM - Armenia 5
CO - Colombia 5
JO - Giordania 5
MY - Malesia 5
PK - Pakistan 5
UY - Uruguay 5
GR - Grecia 4
ID - Indonesia 4
IR - Iran 4
TN - Tunisia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
LU - Lussemburgo 3
MA - Marocco 3
AU - Australia 2
EG - Egitto 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.462
Salva come PNG Salva come JPEG
Città #
Ashburn 369
Singapore 327
Fairfield 252
San Jose 196
Chandler 168
Woodbridge 154
Hong Kong 145
Wilmington 132
Jacksonville 119
Ann Arbor 117
Houston 112
Seattle 100
Cambridge 81
Zgierz 80
Dublin 74
Frankfurt am Main 71
Moscow 68
Tokyo 66
Medford 62
Santa Clara 60
Des Moines 57
Hefei 55
Beijing 51
Nanjing 50
Palermo 46
Ho Chi Minh City 43
Kraków 40
Princeton 39
Altamura 37
Council Bluffs 37
Boardman 34
Tulsa 34
Lauterbourg 31
Los Angeles 28
Buffalo 25
Dearborn 25
Ludwigshafen am Rhein 22
Munich 22
Hanoi 21
Lawrence 21
Chicago 20
Kitzingen 20
New York 20
Seoul 20
Dallas 18
Nanchang 17
San Diego 17
São Paulo 17
Milan 16
Shenyang 16
Orem 15
Changsha 14
Saint Petersburg 13
Verona 13
Brussels 12
Seongnam 12
Tianjin 12
Helsinki 11
Nuremberg 11
Rome 11
Guangzhou 10
London 10
Da Nang 9
Hebei 9
Naples 9
Brooklyn 8
Columbus 8
Denver 8
Belo Horizonte 7
Jiaxing 7
San Francisco 7
Turku 7
Istanbul 6
San Mateo 6
The Dalles 6
Amsterdam 5
Auburn Hills 5
Baghdad 5
Cardiff 5
Kunming 5
Montevideo 5
Montreal 5
Rio de Janeiro 5
Taizhou 5
Yerevan 5
Amman 4
Caracas 4
Chennai 4
City of London 4
Düsseldorf 4
Haiphong 4
Johannesburg 4
Ningbo 4
Nürnberg 4
Phoenix 4
Riyadh 4
Shanghai 4
Stockholm 4
Abidjan 3
Acquedolci 3
Totale 4.001
Salva come PNG Salva come JPEG
Nome #
Founder mutations in BRCA1 and BRCA2 genes 298
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 284
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 270
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 267
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 263
Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study 226
Randomized Multicenter Phase II Trial of Two Different Schedules of Irinotecan Combined with Capecitabine as First-Line Treatment in Metastatic Colorectal Carcinoma 219
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 202
Cancer in the older person 195
Reticulocytes can represent an early indicator of erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy 193
Cancer chemotherapy in the older cancer patient 187
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 185
Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG) 173
Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis. 172
1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report 171
EMATOPOIESI E INVECCHIAMENTO 169
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O). 164
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer 157
Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial. 155
Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer A SICOG Phase II Study 155
Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings 146
Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect? 143
FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE. 141
Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring 140
Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC) 135
Oncogeriatry: Communication, sharing, coordination of an emerging reality. The IIIrd Official Meeting of the AIOM Working Group on Oncogeriatry 132
Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients 131
Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people. 130
Myelotoxicity from cytostatic treatment, an important risk factor in the management of neoplasias in the elderly 127
Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy. 127
Sex and Gender in Ageing and Longevity: Highlights from an International Course 125
Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer 123
VEGF and Chromogranin A (CgA): Possible new predictive factors in management of advanced prostatic cancer (APC) in elderly patients 120
VEGF values as a predictive factor of treatment efficiency in elderly women with advanced breast cancer 116
Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation. 111
Safety and efficacy of two different schedules of capecitabine combined with oxaliplatin in the treatment of colon cancer in the elderly 105
SAFETY AND EFFICACY OF INHALED IL-2 THERAPY IN PRE-TREATED BREAST CANCER ELDERLY PATIENTS WITH PULMONARY METASTASES. 100
Non-Pegylated Liposomal Doxorubicin/Cyclophosphamide-based schedule As Antiangiogenic Treatment In Elderly Women With Advanced Breast Cancer 99
VEGF levels could affect outcomes in elderly breast cancer women 93
Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome. 86
Totale 6.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022376 20 95 7 9 9 17 14 17 47 51 22 68
2022/2023531 71 93 0 38 86 79 45 37 51 1 24 6
2023/2024256 13 39 9 10 17 27 26 54 10 6 10 35
2024/2025626 6 34 37 75 14 25 60 52 37 60 66 160
2025/20262.393 184 78 146 151 159 328 284 239 178 510 71 65
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 6.535